http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200736241-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95585944cd76ddfb6dc33ed2a0b84403 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L23-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D301-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-40 |
| filingDate | 2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a59cd0343faf12cfd3b3aecd57dcf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa38ba6ed99e0a20b40010d274cf1f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5233583040cfdfbbef9317fd30fb6802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620855a825362878a13be31bd41c8cc4 |
| publicationDate | 2007-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200736241-A |
| titleOfInvention | Adamantane derivative, composition comprising the derivative, and optical and electronic member using the composition |
| abstract | Disclosed are: an adamantane derivative which can provide a cured product excellent in optical properties including transparency and light resistance, long-term heat resistance, and electrical properties including permittivity; a compound having an adamantane skeleton; a composition comprising the derivative or the compound; and an optical and electronic member using the composition. The adamantane derivative is represented by the general formula (I), and the compound having an adamantane skeleton is represented by the general formula (VII) or (VIII), wherein W represents a hydrogen atom or the like; X represents a group represented by the general formula (II) or the like; Y represents a group represented by the general formula (V) or (VI); R1 represents a methyl or ethyl group; R2 represents a hydrocarbon group having 1 to 10 carbon atoms which may have O or S; m represents an integer of 2 to 4; k represents an integer of 0 to (16-m); and p and q independently represent an integer of 1 to 5. |
| priorityDate | 2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.